Literature DB >> 23009745

Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation.

Flávia Castro Ribas Souza1, Nathália Brandão Gobbato, Rafaela Guerra Maciel, Carla Máximo Prado, Mílton Arruda Martins, Edna A Leick, Iolanda F L Calvo Tibério.   

Abstract

UNLABELLED: We evaluated the effects of anti-iNOS (1400W - W) associated with leukotriene antagonist (montelukast - M) or corticosteroid (dexamethasone - D) on distal lung of guinea pigs (GP) with chronic pulmonary inflammation.
METHODS: GP were inhaled with ovalbumin (OVA-2×/week/4 weeks), treated with M (OVAM), D (OVAD) and/or W (OVAW, OVADW, OVAMW) and distal lungs were evaluated by morphometry.
RESULTS: Isolated treatments were not sufficient to reduce all parameters. In OVADW, all parameters were reduced with greater reduction in elastic fibers, TIMP-1, IL-4, IL-5, IFN-gamma and PGF2-alpha compared with OVAD (p<0.05). OVAMW potentiated the reduction of actin, elastic fibers, TIMP-1, IL-4, IL-5, TGF-beta, IFN-gamma, iNOS, and PGF2-alpha to a greater extent than OVAM (p<0.05). A reduction of TIMP-1, IL-4, IL-5, TGF-beta, IFN-gamma and iNOS was observed in OVADW compared with OVAMW (p<0.05).
CONCLUSIONS: Although anti-iNOS paired with montelukast or dexamethasone yields better results than isolated treatments, the most effective pairing for controlling inflammation, oxidative stress and remodeling in this asthma model was found to be corticosteroids and anti-iNOS.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23009745     DOI: 10.1016/j.resp.2012.08.015

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  6 in total

1.  15-Lipoxygenase inhibition of Commelina benghalensis, Tradescantia fluminensis, Tradescantia zebrina.

Authors:  Cean Socorro M Alaba; Christine L Chichioco-Hernandez
Journal:  Asian Pac J Trop Biomed       Date:  2014-03

2.  Antileukotriene reverts the early effects of inflammatory response of distal parenchyma in experimental chronic allergic inflammation.

Authors:  Nathália Brandão Gobbato; Flávia Castro Ribas de Souza; Stella Bruna Napolitano Fumagalli; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Carla Máximo Prado; Milton Arruda Martins; Iolanda de Fátima Lopes Calvo Tibério; Edna Aparecida Leick
Journal:  Biomed Res Int       Date:  2013-09-15       Impact factor: 3.411

3.  Interstitial collagen turnover during airway remodeling in acute and chronic experimental asthma.

Authors:  Georgina González-Avila; Blanca Bazan-Perkins; Cuauhtémoc Sandoval; Bettina Sommer; Sebastian Vadillo-Gonzalez; Carlos Ramos; Arnoldo Aquino-Galvez
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

4.  Y-27632 is associated with corticosteroid-potentiated control of pulmonary remodeling and inflammation in guinea pigs with chronic allergic inflammation.

Authors:  Patricia Angeli Pigati; Renato Fraga Righetti; Samantha Souza Possa; Beatriz Saraiva Romanholo; Adriana Palmeira Dias Rodrigues; Anelize Sartori Alves dos Santos; Débora Gonçalves Xisto; Mariana Alves Antunes; Carla Máximo Prado; Edna Aparecida Leick; Milton de Arruda Martins; Patrícia Rieken Macedo Rocco; Iolanda de Fátima Lopes Calvo Tibério
Journal:  BMC Pulm Med       Date:  2015-08-12       Impact factor: 3.317

5.  Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-κB-mediated inflammatory response.

Authors:  Xuanfei Li; Zheng Liu; He Jin; Xia Fan; Xue Yang; Wanqi Tang; Jun Yan; Huaping Liang
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 6.  Evidences of Herbal Medicine-Derived Natural Products Effects in Inflammatory Lung Diseases.

Authors:  Fernanda Paula R Santana; Nathalia M Pinheiro; Márcia Isabel B Mernak; Renato F Righetti; Mílton A Martins; João H G Lago; Fernanda D T Q Dos Santos Lopes; Iolanda F L C Tibério; Carla M Prado
Journal:  Mediators Inflamm       Date:  2016-06-29       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.